Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. (Q38010556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

0 references

1 reference

Concepción M Aguilera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Angel Gil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Oscar D Rangel-Huerta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

María D Mesa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Oscar D Rangel-Huerta

1

object named as

Oscar D Rangel-Huerta

1 reference

26 August 2017

Maria D Mesa

3

1 reference

26 August 2017

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Nutrition

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

107 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

S159-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Origin and physiological roles of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

n-3 polyunsaturated fatty acids do not alter immune and inflammation measures in endurance athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Anti-inflammatory and proresolving lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Specialized pro-resolving lipid mediators in the inflammatory response: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Omega-3 fatty acids in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Lipoxins and new lipid mediators in the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

The effects of diet on inflammation: emphasis on the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Aging and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdeh

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of healthy adults

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Inflammation resolution: does the bone marrow have a say?

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Quercetin reduces illness but not immune perturbations after intensive exercise

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Polyunsaturated fatty acids and inflammation

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects--A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans

1 reference

https://api.crossref.org/works/10.1017%2FS0007114512001559

7 January 2021

10.1017/S0007114512001559

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591890%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference